Balchem Corp (BCPC) capitalization

Current snapshot

Market Cap
$5.45B
32.1M shares × $169.48 · as of last filing 2026-03-31
Net Worth
$1.29B
Stockholders' equity · 2026-03-31
Enterprise Value
$5.41B
Market cap + debt − cash
Net Debt
-$35.5M
Debt $37.4M − Cash $72.9M

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-31 $5.00B
FY'24 2024-12-31 $5.33B
FY'23 2023-12-31 $4.83B
FY'22 2022-12-31 $3.96B
FY'21 2021-12-31 $5.51B
FY'20 2020-12-31 $3.74B
FY'19 2019-12-31 $3.30B
FY'18 2018-12-31 $2.54B
FY'17 2017-12-31 $2.60B
FY'16 2016-12-31 $2.68B
FY'15 2015-12-31 $1.92B
FY'14 2014-12-31 $2.08B
FY'13 2013-12-31 $1.81B
FY'12 2012-12-31 $1.11B
FY'11 2011-12-31 $1.23B
FY'11 2010-12-31 $1.00B
FY'11 2009-12-31 $967.6M

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q1'26 2026-03-31 $5.47B
Q4'25 2025-12-31 $4.92B
Q3'25 2025-09-30 $4.89B
Q2'25 2025-06-30 $5.20B
Q1'25 2025-03-31 $5.45B
Q4'24 2024-12-31 $5.30B
Q3'24 2024-09-30 $5.77B
Q2'24 2024-06-30 $5.03B
Q1'24 2024-03-31 $5.06B
Q4'23 2023-12-31 $4.80B
Q3'23 2023-09-30 $4.03B
Q2'23 2023-06-30 $4.37B
Q1'23 2023-03-31 $4.10B
Q4'22 2022-12-31 $3.93B
Q3'22 2022-09-30 $3.94B
Q2'22 2022-06-30 $4.19B
Q1'22 2022-03-31 $4.44B
Q4'21 2021-12-31 $5.44B
Q3'21 2021-09-30 $4.74B
Q2'21 2021-06-30 $4.29B
Q1'21 2021-03-31 $4.10B
Q4'20 2020-12-31 $3.73B
Q3'20 2020-09-30 $3.17B
Q2'20 2020-06-30 $3.08B
Q1'20 2020-03-31 $3.21B
Q4'19 2019-12-31 $3.27B
Q3'19 2019-09-30 $3.22B
Q2'19 2019-06-30 $3.26B
Q1'19 2019-03-31 $3.02B
Q4'18 2018-12-31 $2.53B
Q3'18 2018-09-30 $3.65B
Q2'18 2018-06-30 $3.18B
Q1'18 2018-03-31 $2.64B
Q4'17 2017-12-31 $2.58B
Q3'17 2017-09-30 $2.62B
Q2'17 2017-06-30 $2.50B
Q1'17 2017-03-31 $2.65B
Q4'16 2016-12-31 $2.67B
Q3'16 2016-09-30 $2.48B
Q2'16 2016-06-30 $1.90B
Q1'16 2016-03-31 $1.97B
Q4'15 2015-12-31 $1.92B
Q3'15 2015-09-30 $1.93B
Q2'15 2015-06-30 $1.76B
Q1'15 2015-03-31 $1.74B
Q4'14 2014-12-31 $2.06B
Q3'14 2014-09-30 $1.77B
Q2'14 2014-06-30 $1.67B
Q1'14 2014-03-31 $1.62B
Q4'13 2013-12-31 $1.77B
Q3'13 2013-09-30 $1.60B
Q2'13 2013-06-30 $1.38B
Q1'13 2013-03-31 $1.35B
Q4'12 2012-12-31 $1.07B
Q3'12 2012-09-30 $1.12B
Q2'12 2012-06-30 $987.2M
Q1'12 2012-03-31 $917.6M
Q4'11 2011-12-31 $1.18B
Q3'11 2011-09-30 $1.13B
Q2'11 2011-06-30 $1.32B
Q1'12 2011-03-31 $1.13B
Q4'11 2010-12-31 $972.1M
Q3'11 2010-09-30
Q2'11 2010-06-30
Q4'11 2009-12-31 $967.6M

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (BCPC CIK 0000009326), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

GIII

G III APPAREL GROUP LTD /DE/

PRCT

PROCEPT BioRobotics Corporation

AMRX

Amneal Pharmaceuticals, Inc.